Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecka Papaioannu-Borjesson

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Review of Anti-Infective Therapy|July 7, 2025
Addressing late HIV presentation: the current knowledge and unmet needsTommaso Clemente, Rebecka Papaioannu-Borjesson, Antonella Castagna, et al.
Antibiotics (Basel, Switzerland)|October 28, 2025
Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective EndocarditisRoberta Monardo, Rebecka Papaioannu Borjesson, Giacomo Ponta, et al.
Expert Opinion on Pharmacotherapy|February 25, 2026
Highlighting advances on clinical management of pediatric HIVRebecka Papaioannu Borjesson, Tommaso Clemente, Antonella Castagna, et al.
The New Microbiologica|November 19, 2024
PRESTIGIO RING: "A 28-year-old highly treatmentexperienced man with vertical HIV infection on ibalizumab therapy: ART simplification perspectives"Rebecka Papaioannu Borjesson, Maurizio Zazzi, Francesco Saladini, et al.
HIV Medicine|February 2, 2026
Hypertriglyceridaemia and gender differences in the risk of major adverse cardiovascular events in people with HIV: A single-centre retrospective longitudinal studyAlessia Siribelli, Nicolò Capra, Riccardo Lolatto, et al.
Frontiers in Medicine|October 4, 2023
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemicRebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
AIDS (London, England)|November 15, 2023
Sexually transmitted infections in people with multidrug-resistant HIVTommaso Clemente, Riccardo Lolatto, Rebecka Papaioannu Borjesson, et al.
HIV Medicine|April 30, 2026
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment eraTommaso Clemente, Pierluigi Reali, Riccardo Lolatto, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Review of Anti-Infective Therapy|July 7, 2025
Addressing late HIV presentation: the current knowledge and unmet needsTommaso Clemente, Rebecka Papaioannu-Borjesson, Antonella Castagna, et al.
Antibiotics (Basel, Switzerland)|October 28, 2025
Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective EndocarditisRoberta Monardo, Rebecka Papaioannu Borjesson, Giacomo Ponta, et al.
Expert Opinion on Pharmacotherapy|February 25, 2026
Highlighting advances on clinical management of pediatric HIVRebecka Papaioannu Borjesson, Tommaso Clemente, Antonella Castagna, et al.
The New Microbiologica|November 19, 2024
PRESTIGIO RING: "A 28-year-old highly treatmentexperienced man with vertical HIV infection on ibalizumab therapy: ART simplification perspectives"Rebecka Papaioannu Borjesson, Maurizio Zazzi, Francesco Saladini, et al.
HIV Medicine|February 2, 2026
Hypertriglyceridaemia and gender differences in the risk of major adverse cardiovascular events in people with HIV: A single-centre retrospective longitudinal studyAlessia Siribelli, Nicolò Capra, Riccardo Lolatto, et al.
Frontiers in Medicine|October 4, 2023
Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemicRebecka Papaioannu Borjesson, Laura Galli, Camilla Muccini, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
AIDS (London, England)|November 15, 2023
Sexually transmitted infections in people with multidrug-resistant HIVTommaso Clemente, Riccardo Lolatto, Rebecka Papaioannu Borjesson, et al.
HIV Medicine|April 30, 2026
Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment eraTommaso Clemente, Pierluigi Reali, Riccardo Lolatto, et al.
Pageof 2